YBX1 and neoplasm: Additionally, YBX1 influences tumor-associated angiogenesis and invasion [112,113] and augments the lytic activity of oncolytic adenoviruses against YBX1-positive tumor cells, thereby promoting the release of tumor-associated antigens and cytokines [114,115], or acting directly as a tumor-associated antigen to activate both humoral and cellular immunity.